A Prospective, Multicenter, Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the JOURNEY™ II XR Total Knee System
This study was designed to demonstrate the safety and performance of the JOURNEY II XR total knee system by evaluating implant survival rates at 10 years using Kaplan-Meier analysis. All participants will be implanted with the JOURNEY II XR total knee system.
• require TKA due to rheumatoid arthritis, post-traumatic arthritis, osteoarthritis, or degenerative arthritis, failed osteotomies, or failed unicompartmental replacement
• have all cruciate and collateral ligaments intact in the index joint
• adult patients that in the judgement of the Investigator are skeletally mature
• be willing and able to participate in required follow-up visits at the investigational site and to complete study procedures and questionnaires
• consent to participate in the study by signing the IRB/EC approved informed consent form